Dinutuximab, a first new drug for the specific treatment of high-risk neuroblastomaHAN Jin-e, HUI Ren-jie, FENG Bai-nian241-243,269
Development of the United States regulatory policy about the laboratory developed test (LDT)LIU Dong-lai, SHI Da-wei, ZHANG Chun-tao244-252
Analysis of India compulsory license system of drug patent and the enlightenment to ChinaYU Cheng-hang, TIAN Kan, YU Xiao-yong253-257
Prediction of procurement funds of essential medicines in primary medical institutions based on BP neural networkCHU Shu-zhen, ZHANG Huan-yu, CHEN Lu258-261,276
Germany medicare payment system and its implication to ChinaWANG Ya-nan, PENG Xiao-chen, CHENG Yue, SUN Li-hua262-265
Progress in the research of New Delhi metallo-β-lactamase-1 and its inhibitorsLI Xing-hua, XIAO Chun-ling270-276
Application of recombinant human metabolic enzyme yeast system in metabolic research of new drug in vitroCHEN Lu, QIAN Wen, YANG Chang-qing277-282
Immunomodulatory properties-based strategy for the assessment of biological effectiveness of mesenchymaistem cellsZHANG Ke-hua, NA Tao, HAN Xiao-yan, YUAN Bao-zhu283-290
Recent progress in small molecular ligands of thyroid-stimulating hormone receptor任航, 申慧芳, 李官成, 王滔, 李铭源, 牛少娜, 刘爱武, 崔国祯291-296